Imagen de Portada
Código QR

Botulinum Tx improves QoL in idiopathic OAB: dose-response association is maintained through 36 weeks, data from multicenter study show.

Publicado en:Urology Times Vol. 37; no. 8; pp. 12 - 13
Autor principal: Kuznar W
Formato: brief item Journal Article
Publicado: MJH Life Sciences 7/1/2009
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105409769&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105409769
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: 7/1/2009
      vid: 37
      iid: 8
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        105409769
        105409769
        2010366880
        105409769
      ppf: 12
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Botulinum Tx improves QoL in idiopathic OAB: dose-response association is maintained through 36 weeks, data from multicenter study show.
      aug:
        au: Kuznar W
      sug:
        subj:
          Botulinum Toxins Administration and Dosage
          Injections
          Overactive Bladder Drug Therapy
          Clinical Trials
          Patient Satisfaction
          Quality of Life
          Questionnaires
          Time Factors
          Treatment Outcomes
      pubtype: Academic Journal
      doctype:
        brief item
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N